BFA
CASI

BlackRock Fund Advisors’s CASI Pharmaceuticals CASI Stock Holding History

BlackRock Fund Advisors’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$44K Buy
3,789
+193
+5% +$2.64K ﹤0.01% 3784
2016
Q3 		$40K Buy
3,596
+30
+0.8% +$329 ﹤0.01% 3821
2016
Q2 		$42K Sell
3,566
-39
-1% -$492 ﹤0.01% 3853
2016
Q1 		$38K Sell
3,605
-216
-6% -$2.09K ﹤0.01% 3847
2015
Q4 		$37K Buy
3,821
+323
+9% +$3.67K ﹤0.01% 3914
2015
Q3 		$37K Sell
3,498
-93
-3% -$1.34K ﹤0.01% 3862
2015
Q2 		$64K Buy
3,591
+433
+14% +$6.47K ﹤0.01% 3798
2015
Q1 		$47K Sell
3,158
-214
-6% -$3.37K ﹤0.01% 3703
2014
Q4 		$45K Buy
3,372
+241
+8% +$3.78K ﹤0.01% 3682
2014
Q3 		$56K Buy
+3,131
New +$55.7K ﹤0.01% 3697
2014
Q2 		– Sell
-3,263
Closed -$59K – 3859
2014
Q1 		$59K Buy
3,263
+396
+14% +$7.49K ﹤0.01% 3642
2013
Q4 		$48K Buy
2,867
+120
+4% +$2.03K ﹤0.01% 3662
2013
Q3 		$49K Buy
2,747
+216
+9% +$4.1K ﹤0.01% 3635
2013
Q2 		$51K Buy
+2,531
New +$49.1K ﹤0.01% 3606

Other funds holding CASI

WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock Fund Advisors's CASI Position: Q4 2016 in Review

BlackRock Fund Advisors increased its CASI Pharmaceuticals (CASI) stake by 5.4% in Q4 2016, buying an estimated $2.64K and bringing the position to 3,789 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #3784.

BlackRock Fund Advisors first reported a position in CASI in Q2 2013 and has held it in 14 quarters since. The position peaked at $64K in Q2 2015. 28 funds tracked by Wall St. Rank hold CASI as of Q4 2016.

  • BlackRock Fund Advisors held 3,789 shares of CASI Pharmaceuticals worth $44K as of Q4 2016.
  • BlackRock Fund Advisors bought 193 CASI Pharmaceuticals shares in Q4 2016, an estimated $2.64K.
  • CASI Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3784 holding.
  • BlackRock Fund Advisors first reported a position in CASI Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
  • BlackRock Fund Advisors's CASI Pharmaceuticals position peaked at $64K in Q2 2015.
  • 28 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.